SACHS BRUCE I — SEC insider filings

SEC reporting owner CIK 1197036. 40 insider filings on record with FilingPulse; latest filed 2026-10-19.

Transaction summary — filings shown

Covers all 40 filings on record, filed 2020-10-19 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERTEX PHARMACEUTICALS INC / MA (VRTX)Director406 legs · 35,000 sh · $8,177,53110 legs · 57,368 sh · $21,552,70745

Insider filings — SACHS BRUCE I

FiledFormIssuerReported transactionsSource
2026-10-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 92.69 (derivative) @ $512.44EDGAR
2026-08-314VERTEX PHARMACEUTICALS INC / MA (VRTX)Gift (G): 6,000 @ $0EDGAR
2026-07-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 99.94 (derivative) @ $475.28EDGAR
2026-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,866 (derivative) @ $0EDGAR
2026-04-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 107.34 (derivative) @ $442.50EDGAR
2026-01-204VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 107.09 (derivative) @ $443.56EDGAR
2025-10-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 115.77 (derivative) @ $410.31EDGAR
2025-08-074VERTEX PHARMACEUTICALS INC / MA (VRTX)Purchase (P): 1,634 @ $389.36 · Purchase (P): 3,366 @ $389.84EDGAR
2025-07-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 101.21 (derivative) @ $469.34EDGAR
2025-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,398 (derivative) @ $0EDGAR
2025-04-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 95.47 (derivative) @ $497.51EDGAR
2025-01-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 111.65 (derivative) @ $420.31EDGAR
2024-10-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 90.32 (derivative) @ $484.39EDGAR
2024-08-024VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 5,295 @ $125.71 · Sale (S): 5,295 @ $508 · Option exercise (M): 5,295 (derivative) @ $0EDGAR
2024-07-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 89.26 (derivative) @ $490.12EDGAR
2024-05-244VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 7,073 @ $93.51 · Sale (S): 7,073 @ $448 · Option exercise (M): 7,073 (derivative) @ $0EDGAR
2024-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 3,142 (derivative) @ $0EDGAR
2024-04-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 109.49 (derivative) @ $399.58EDGAR
2024-01-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 101.04 (derivative) @ $432.99EDGAR
2023-11-084VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 11,250 @ $127.54 · Sale (S): 11,250 @ $385 · Option exercise (M): 11,250 (derivative) @ $0EDGAR
2023-10-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 118.25 (derivative) @ $369.98EDGAR
2023-07-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 11,250 @ $127.54 · Sale (S): 1,697 @ $355.54 · Sale (S): 5,711 @ $356.75 · Sale (S): 3,842 @ $357.29 · Grant/award (A): 124.72 (derivative) @ $350.79 · Option exercise (M): 11,250 (derivative) @ $0EDGAR
2023-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 3,481 (derivative) @ $0EDGAR
2023-04-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 131.47 (derivative) @ $332.77EDGAR
2023-04-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 21,300 @ $72.14 · Sale (S): 2,917 @ $325.65 · Sale (S): 10,357 @ $326.46 · Sale (S): 8,026 @ $327.48 · Gift (G): 1,210 @ $0 · Option exercise (M): 21,300 (derivative) @ $0EDGAR
2023-02-024VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 1,200 @ $72.14 · Sale (S): 1,200 @ $325.01 · Option exercise (M): 1,200 (derivative) @ $0EDGAR
2023-01-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 146.61 (derivative) @ $298.42EDGAR
2022-10-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 147.40 (derivative) @ $296.82EDGAR
2022-07-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 151.26 (derivative) @ $289.23EDGAR
2022-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 4,462 (derivative) @ $0EDGAR
2022-04-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 151.17 (derivative) @ $289.41EDGAR
2022-01-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 189.74 (derivative) @ $230.58EDGAR
2021-10-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 240.29 (derivative) @ $182.07EDGAR
2021-08-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Purchase (P): 15,000 @ $197.91EDGAR
2021-07-164VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 220.96 (derivative) @ $198EDGAR
2021-05-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 6,067 (derivative) @ $0EDGAR
2021-04-164VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 198.71 (derivative) @ $220.17EDGAR
2021-01-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 193.59 (derivative) @ $225.99EDGAR
2020-11-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Purchase (P): 6,825 @ $216.47 · Purchase (P): 4,270 @ $217.49 · Purchase (P): 3,905 @ $218.79EDGAR
2020-10-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 196.36 (derivative) @ $222.81EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-19 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1197036 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs